Treatment

RAMUCIRUMAB, AFM24, AFM24, ATEZOLIZUMAB, DOCETAXEL, DOCETAXEL, ATEZOLIZUMAB clinical trials

1 indexed studies · 0 currently recruiting

Ongoing, recruitingPhase I and Phase II (Integrated)- Other
A Phase 1/2a Open Label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy of AFM24 in Combination with Atezolizumab in Patients with Selected Advanced/Metastatic EGFR-expressing Cancers
This study is looking at a new combination of treatments, AFM24 and Atezolizumab, for certain advanced cancers that have a specific marker (EGFR). We want to find out if it's safe, how it works in the body, and if it can shrink these cancers.
For: Advanced/Metastatic EGFR-expressing Cancers
Poland · Spain